Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles, Cellular/Molecular

Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain

Henry K. Karlsson, Lauri Tuominen, Jetro J. Tuulari, Jussi Hirvonen, Riitta Parkkola, Semi Helin, Paulina Salminen, Pirjo Nuutila and Lauri Nummenmaa
Journal of Neuroscience 4 March 2015, 35 (9) 3959-3965; DOI: https://doi.org/10.1523/JNEUROSCI.4744-14.2015
Henry K. Karlsson
1Turku PET Centre, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauri Tuominen
1Turku PET Centre, and
2Departments of Psychiatry,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jetro J. Tuulari
1Turku PET Centre, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jussi Hirvonen
1Turku PET Centre, and
3Radiology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riitta Parkkola
3Radiology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Semi Helin
1Turku PET Centre, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulina Salminen
4Surgery, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paulina Salminen
Pirjo Nuutila
1Turku PET Centre, and
5Endocrinology, Turku University Hospital, FI-20520 Turku, Finland, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauri Nummenmaa
1Turku PET Centre, and
6Department of Neuroscience and Biomedical Engineering, School of Science, Aalto University, FI-00076 Aalto, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Averaged images of [11C]carfentanil and [11C]raclopride showing lowered MOR availability but unaltered D2R availability among obese patients.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Brain regions showing lowered MOR availability in morbidly obese patients versus healthy control subjects. The data are thresholded at p < 0.05, FDR corrected. The blue outline shows regions where the effect is significant at a more stringent statistical threshold (p < 0.01, FDR corrected).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Mean [11C]carfentanil and [11C]raclopride BPND in regions of interest. Note: MOR data show a main effect of group (obese < lean) with no interaction with ROI. *p < 0.05 in complementary contrast test.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Scatterplots illustrating the relationship between BMI and BPND in ventral striatum, dorsal caudate, and putamen.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Random-effects analysis for the effects of obesity on D2R availability in PET studies using [11C]raclopride. RE, Random effects.

Tables

  • Figures
    • View popup
    Table 1.

    Characteristics of the participants

    Obese subjects (n = 13)Nonobese subjects (n = 14)p value*
    MeanSDMeanSD
    Age (years)39.0810.7444.8612.880.22
    Weight (kg)116.8216.6061.397.19<0.001
    Height (cm)166.276.94164.866.320.59
    BMI (kg/m2)41.893.8822.652.94<0.001
    Fat (%)50.444.0630.2110.17<0.001
    Subcutaneous fat mass (kg)17.503.534.161.28<0.001
    Visceral fat mass (kg)3.602.180.780.44<0.001
    HbA1c (%)5.520.395.600.300.50
    Systolic blood pressure (mmHg)129.6412.72129.5413.750.99
    Diastolic blood pressure (mmHg)83.278.8180.238.250.40
    Amount of alcohol use (drinks/week)1.501.352.752.090.10
    Tobacco smokers/nonsmokers (N)5/130/14<0.001
    Injected activity of [11C]raclopride (MBq)243.8427.83257.7818.510.14
    Injected activity of [11C]carfentanil (MBq)251.0010.38250.149.230.82
    • HbA1c, Glycated hemoglobin A1c.

    • ↵*Between-groups differences; significant differences in two-sample t test are shown in bold.

    • View popup
    Table 2.

    Questionnaire scores

    Obese subjects (n = 13)Nonobese subjects (n = 14)p value*
    MeanSDMeanSD
    BDI-II5.925.774.364.110.43
    STAI38.779.1434.075.470.12
    BIS13.463.1816.642.790.01
    BAS
        Drive9.924.278.712.550.39
        Fun seeking11.083.0910.572.440.64
        Reward responsiveness10.003.6310.501.830.66
    FCQ
        State30.9210.3226.716.280.22
        Trait104.3135.3486.2125.610.14
    DEBQ
        Restrained eating33.545.6626.006.180.003
        Emotional eating31.0011.3122.076.330.02
        External eating26.316.7325.365.760.70
    YFAS18.0011.007.865.950.009
    • ↵*Between-groups differences; significant differences in two-sample t test are shown in bold.

Back to top

In this issue

The Journal of Neuroscience: 35 (9)
Journal of Neuroscience
Vol. 35, Issue 9
4 Mar 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain
Henry K. Karlsson, Lauri Tuominen, Jetro J. Tuulari, Jussi Hirvonen, Riitta Parkkola, Semi Helin, Paulina Salminen, Pirjo Nuutila, Lauri Nummenmaa
Journal of Neuroscience 4 March 2015, 35 (9) 3959-3965; DOI: 10.1523/JNEUROSCI.4744-14.2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain
Henry K. Karlsson, Lauri Tuominen, Jetro J. Tuulari, Jussi Hirvonen, Riitta Parkkola, Semi Helin, Paulina Salminen, Pirjo Nuutila, Lauri Nummenmaa
Journal of Neuroscience 4 March 2015, 35 (9) 3959-3965; DOI: 10.1523/JNEUROSCI.4744-14.2015
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • dopamine
  • obesity
  • opioids
  • positron emission tomography
  • receptors
  • reward

Responses to this article

Respond to this article

Jump to comment:

  • Important indication of opioid involvement in obesity
    David L. Margules
    Published on: 05 March 2015
  • Published on: (5 March 2015)
    Page navigation anchor for Important indication of opioid involvement in obesity
    Important indication of opioid involvement in obesity
    • David L. Margules, Professor

    I am pleased to see this confirmation and extension of our discovery 37 years ago in genetically obese mice and rats.

    Margules, D. L., Moisset, B., Lewis, M. J., Shibuya, H., & Pert, C. B. (1978). Beta-endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science, 202, 988-991.

    It extends our discovery to humans, shows how much of the brain is involved, rules...

    Show More

    I am pleased to see this confirmation and extension of our discovery 37 years ago in genetically obese mice and rats.

    Margules, D. L., Moisset, B., Lewis, M. J., Shibuya, H., & Pert, C. B. (1978). Beta-endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science, 202, 988-991.

    It extends our discovery to humans, shows how much of the brain is involved, rules out dopamine involvement and implicates the opioid receptors.

    Nice job!

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles

Cellular/Molecular

  • Carbogen-induced respiratory acidosis blocks experimental seizures by a direct and specific inhibition of NaV1.2 channels in the axon initial segment of pyramidal neurons
  • Synaptotagmin 9 Modulates Spontaneous Neurotransmitter Release in Striatal Neurons by Regulating Substance P Secretion
  • Indirect Effects of Halorhodopsin Activation: Potassium Redistribution, Nonspecific Inhibition, and Spreading Depolarization
Show more Cellular/Molecular
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.